I
INOVIO is a clinical stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. Our mission: deliver on the promise of DNA medicine for patients around the world. For more information, visit www.inovio.com.
Investor insights
Funding rounds participated in
$30M sweet spot round size
Investor type
Public Company
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Funding rounds raised
Total raised
$30M
from investors over 1 rounds
I
INOVIO Pharmaceuticals, Inc. raised $30M on January 13, 2025